Psychedelic therapy near you: what you can actually book in 2026
Cut through the marketing: what's bookable depends on the medicine and your state. Ketamine is prescribable everywhere today. Psilocybin has two licensed states. MDMA is trials-only. Here is the honest availability map, drawn from 2,023 US clinics and 314 recruiting trial sites in the index.
What's available where you live
Ketamine & esketamine
The one psychedelic-adjacent medicine already prescribable nationwide. Esketamine (Spravato) carries FDA approval for treatment-resistant depression; ketamine clinics run under standard medical practice. We track 1,942 US clinics; check any record to see exactly what it administers.
legal nationwidePsilocybin, licensed
24 Oregon service centers with an OHA license on record, and 47 Colorado healing centers approved on the state register, run supervised sessions under state licensure. Screening is mandatory; SSRIs, lithium and psychosis history are the usual exclusions. Out of pocket, $1,000–$3,000.
licensed programClinical trials
The legal route for psilocybin, MDMA and LSD outside the licensed states, and better than its reputation: medical teams, no cost to participate, and most active studies target depression, PTSD, addiction and end-of-life distress.
314 US trial sites recruitingMDMA-assisted therapy
The FDA declined the 2024 application and asked for another phase 3 trial. Until that lands, "MDMA therapy near me" has one legal answer in the US: a registered study.
trials onlyThe fastest honest paths, by goal
Depression, today: ketamine or esketamine at a licensed clinic; ask specifically which of the two they administer and what a full course costs. Psilocybin specifically: book Oregon or Colorado, or enroll in a trial anywhere else. PTSD: trials are where MDMA lives; several are recruiting now. Not sure: start from the legal map and work backward from what's lawful where you are.